Submitted by Anonymous (not verified) on 21 August 2026 - 10:00
Human medicines European public assessment report (EPAR): Ngenla, somatrogon, Date of authorisation: 14/02/2022, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ngenla, somatrogon, Date of authorisation: 14/02/2022, Revision: 9, Status: Authorised